Matthew Kaplan
Stock Analyst at Ladenburg Thalmann
(3.35)
# 989
Out of 4,711 analysts
27
Total ratings
62.5%
Success rate
12.88%
Average return
Main Sectors:
Stocks Rated by Matthew Kaplan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EYEN Eyenovia | Downgrades: Neutral | n/a | $0.09 | - | 1 | Nov 18, 2024 | |
| UTHR United Therapeutics | Maintains: Buy | $319 → $344 | $359.58 | -4.33% | 9 | Oct 31, 2024 | |
| URGN UroGen Pharma | Maintains: Buy | $48 → $54 | $10.64 | +402.82% | 1 | Jun 14, 2024 | |
| TGTX TG Therapeutics | Maintains: Buy | $39 → $40 | $32.20 | +24.22% | 3 | May 2, 2024 | |
| LQDA Liquidia | Maintains: Buy | $15 → $30 | $11.10 | +170.27% | 2 | Dec 21, 2023 | |
| ARDX Ardelyx | Maintains: Buy | $7.5 → $8.5 | $4.82 | +76.35% | 4 | Aug 3, 2023 | |
| AVDL Avadel Pharmaceuticals | Maintains: Buy | $15 → $16 | $10.31 | +55.19% | 1 | May 2, 2023 | |
| KPRX Kiora Pharmaceuticals | Reiterates: Buy | $1,071 | $3.27 | +32,652.29% | 2 | Feb 8, 2023 | |
| XAIR Beyond Air | Maintains: Buy | $17 → $23 | $0.40 | +5,605.78% | 1 | Jun 29, 2022 | |
| LPCN Lipocine | Upgrades: Buy | $51 | $4.87 | +947.23% | 1 | Dec 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $7.84 | +104.08% | 1 | Oct 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $5.39 | +734.88% | 1 | Jan 22, 2020 |
Eyenovia
Nov 18, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.09
Upside: -
United Therapeutics
Oct 31, 2024
Maintains: Buy
Price Target: $319 → $344
Current: $359.58
Upside: -4.33%
UroGen Pharma
Jun 14, 2024
Maintains: Buy
Price Target: $48 → $54
Current: $10.64
Upside: +402.82%
TG Therapeutics
May 2, 2024
Maintains: Buy
Price Target: $39 → $40
Current: $32.20
Upside: +24.22%
Liquidia
Dec 21, 2023
Maintains: Buy
Price Target: $15 → $30
Current: $11.10
Upside: +170.27%
Ardelyx
Aug 3, 2023
Maintains: Buy
Price Target: $7.5 → $8.5
Current: $4.82
Upside: +76.35%
Avadel Pharmaceuticals
May 2, 2023
Maintains: Buy
Price Target: $15 → $16
Current: $10.31
Upside: +55.19%
Kiora Pharmaceuticals
Feb 8, 2023
Reiterates: Buy
Price Target: $1,071
Current: $3.27
Upside: +32,652.29%
Beyond Air
Jun 29, 2022
Maintains: Buy
Price Target: $17 → $23
Current: $0.40
Upside: +5,605.78%
Lipocine
Dec 10, 2020
Upgrades: Buy
Price Target: $51
Current: $4.87
Upside: +947.23%
Oct 14, 2020
Initiates: Buy
Price Target: $16
Current: $7.84
Upside: +104.08%
Jan 22, 2020
Initiates: Buy
Price Target: $45
Current: $5.39
Upside: +734.88%